Effects of pregnancy serum and scriptaid on development in early partheno embryo

• Main Authors: Min-Gee Oh, Na-Hyeon Jung, Dae-Seung Kim, Jong-Taek Yoon
• Format: Article
• Language: English
• Published: The Korean Society of Animal Reproduction and Biotechnology 2020-06-01
• Series: Journal of Animal Reproduction and Biotechnology
• Subjects: apoptosis; partheno embryo; porcine; pregnancy serum; scriptaid
• Online Access: http://www.e-jarb.org/journal/view.html?uid=2533&vmd=Full

Partheno Embryo's research is known to play a very important role in identifying the development of embryonic cells or analyzing the genetic mechanisms of embryonic development, but the information on apoptosis formed during the early stage of development on Partheno Embryo is very little. Therefore, this study analyzed whether the embryonic cell death of unit embryos can be inhibited by adding Scriptaid, one of HDACi, which plays a role in demethylation of histone proteins as a method of regulating the cell cycle in the early embryo development of Partheno Embryo. As a result, the differentiation rate was higher in the group that added Scriptaid and FBS, but the cellular development was higher in the group that added pregnant serum to Scriptaid. As a result of analyzing the expression of the gene through IF and PCR, the group with the addition of gestational serum increased the expression of BCL2 and PCNA, which affects the anti-Casp3 action in cell survival. In addition, it is interpreted that treatment of Scriptaid for 16 hours, rather than 24 h treatment lowers the expression of Casp-3, a representative factor of apoptosis, and also increases embryonic development, thus affecting early embryo development. Therefore, it is concluded that the 16-hour treatment of Scriptaid and the use of gestational serum will inhibit cell death in the early embryonic development and increase the development rate of the embryo.